Skip to main content

Arcadia names new CEO, forecasts big revenue gains; stock soars

Shares of Davis-based Arcadia Biosciences Inc. rose more than 52% on Monday on a large revenue increase forecast by newly named CEO Matthew Plavan.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.